Lonza appoints Daniel Palmacci as President of the Cell & Gene Division
He takes over leadership of Cell & Gene from Jean-Christophe Hyvert, enabling Jean-Christophe to increase his focus on his role as President of the Biologics Division
He takes over leadership of Cell & Gene from Jean-Christophe Hyvert, enabling Jean-Christophe to increase his focus on his role as President of the Biologics Division
NATCO to sell 15% of shareholding in Nativita for euro 3,45,000 to Pharmasyntez-Nord
He will be responsible for ensuring that every dose of medication that ACG Inspection’s pharmaceutical and nutraceutical partners provide is manufactured and delivered exactly as intended
Christian brings a unique level of experience and expertise from a 20-year career at BASF across multiple territories and businesses
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025
Novel technology combines ACUVUE daily disposable contact lenses with an established antihistamine in FDA- first in its new category
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
Vonage Communications APIs allow developers to easily enhance and build intelligent, intuitive customer experiences directly into their existing applications and devices
Vabysmo is the only injectable eye medicine approved simultaneously in the US for wet AMD and DME, with flexible dosing regimens based on patient need
Nuvaxovid is the first protein-based Covid-19 vaccine to receive approval for provisional registration in Australia
Subscribe To Our Newsletter & Stay Updated